Testing for her2 in breast cancer: current pathology challenges faced in Canada.
| Publicado en: | Current Oncology Vol. 19; no. 6; pp. 315 - 324 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Dec2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109654814&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 109654814 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 11980052 5EKK jtl: Current Oncology issn: 11980052 maglogo: N pubinfo: dt: Dec2012 vid: 19 iid: 6 pid: 97109 pub: MDPI artinfo: ui: 109654814 2011905035 10.3747/co.19.1173 NLM23300357 PMC3503664 109654814 ppf: 315 ppct: 9 formats: fmt: @attributes: type: P tig: atl: Testing for her2 in breast cancer: current pathology challenges faced in Canada. aug: au: Hanna W Barnes P Berendt R Chang M Magliocco A Mulligan AM Rees H Miller N Elavathil L Gilks B Pettigrew N Pilavdzic D Sengupta S affil: University of Toronto, Toronto, ON. ; Sunnybrook and Women's College Health Science Centre, University of Toronto, ON. sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|